Childhood Rhabdomyosarcoma Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options for Childhood Rhabdomyosarcoma
Recurrent Childhood Rhabdomyosarcoma
Treatment options for recurrent childhood rhabdomyosarcoma are based on many factors, including where in the body the cancer has come back, what type of treatment the patient had before, and the needs of the individual child. Treatment may include one or more of the following:
- Chemotherapy with one or more anticancer agents.
- Radiation therapy.
- A clinical trial of new anticancer drugs.
- A clinical trial of targeted therapy.
- A clinical trial of combination chemotherapy and targeted therapy.
- A clinical trial of high-dose chemotherapy followed by stem cell transplant using the patient's own stem cells.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent childhood rhabdomyosarcoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.